| Edward Theodore Ysunza Iv, | |
|
3710 Sw Us Veterans Hospital Rd, Portland, OR 97239-2964 | |
| (503) 220-8262 | |
| Not Available |
| Full Name | Edward Theodore Ysunza Iv |
|---|---|
| Gender | Male |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 3710 Sw Us Veterans Hospital Rd, Portland, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083904015 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | DP170018 (Oregon) | Primary |
| Provider Name | Legacy Good Samaritan Hospital And Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780608216 PECOS PAC ID: 0547179939 Enrollment ID: O20031125000416 |
News Archive
But in the midst of all the uncertainty, administration officials are moving steadily ahead in their efforts to shore up political support for the law while implementing as many of the substantive policy changes as they can. Those dual missions are sometimes in conflict. Officials at the Department of Health and Human Services face pressure to cement the foundation of the law in ways that would be difficult to reverse.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
"Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision, may lie in our interpretation of facial expressions.
News outlets explore some of the unsettled and sticky policy questions - such as what taxes might pay for it, and whether mandates to buy coverage should be included - in the health overhaul legislation.
Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
› Verified 6 days ago
| Provider Name | Legacy Emanuel Hospital & Health Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831112358 PECOS PAC ID: 4587573639 Enrollment ID: O20040127001204 |
News Archive
But in the midst of all the uncertainty, administration officials are moving steadily ahead in their efforts to shore up political support for the law while implementing as many of the substantive policy changes as they can. Those dual missions are sometimes in conflict. Officials at the Department of Health and Human Services face pressure to cement the foundation of the law in ways that would be difficult to reverse.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
"Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision, may lie in our interpretation of facial expressions.
News outlets explore some of the unsettled and sticky policy questions - such as what taxes might pay for it, and whether mandates to buy coverage should be included - in the health overhaul legislation.
Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward Theodore Ysunza Iv, 21540 Nw Franson Way # 2201, Hillsboro, OR 97006-6076 Ph: (503) 858-4641 | Edward Theodore Ysunza Iv, 3710 Sw Us Veterans Hospital Rd, Portland, OR 97239-2964 Ph: (503) 220-8262 |
News Archive
But in the midst of all the uncertainty, administration officials are moving steadily ahead in their efforts to shore up political support for the law while implementing as many of the substantive policy changes as they can. Those dual missions are sometimes in conflict. Officials at the Department of Health and Human Services face pressure to cement the foundation of the law in ways that would be difficult to reverse.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
"Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision, may lie in our interpretation of facial expressions.
News outlets explore some of the unsettled and sticky policy questions - such as what taxes might pay for it, and whether mandates to buy coverage should be included - in the health overhaul legislation.
Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.
› Verified 6 days ago
Barnes Foot And Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 9615 Nw Randall Ln, Portland, OR 97229 Phone: 503-297-2222 | |
Dr. Brian M. Bowen, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1717 Ne 42nd Ave, Suite 3300, Portland, OR 97213 Phone: 503-284-2000 Fax: 503-284-2002 | |
Town Center Foot Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 8305 Se Monterey Ave Ste 101, Portland, OR 97266 Phone: 503-652-1121 Fax: 503-652-2193 | |
Ray A Mcclanahan, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 725 Nw 19th Ave, Portland, OR 97209 Phone: 503-243-2699 Fax: 503-243-2698 | |
Portland Foot And Ankle Institute, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 12672 Nw Barnes Rd Ste 100, Portland, OR 97229 Phone: 503-336-0169 Fax: 503-352-4583 | |
Dr. Steven Gary Tillett, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6274 Sw Capitol Hwy, Portland, OR 97239 Phone: 503-246-2212 |